Vinpocetine protects from aminoglycoside antibiotic-induced hearing loss in guinea pig in vivo

Brain Research

Volumn 868, Issue 2, 2000, Pages 222-229

  Nekrassov, Vladimir ^a   Sitges, María ^b  

^a HOSPITAL GENERAL DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Amikacin; Auditory brainstem response; Na+ channel blockers; Neuroprotection; Ototoxicity

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; SODIUM CHANNEL BLOCKING AGENT; VINPOCETINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN STEM RESPONSE; CONTROLLED STUDY; DRUG EFFECT; GUINEA PIG; HEARING LOSS; LATENT PERIOD; MALE; MORTALITY; NEUROPROTECTION; NONHUMAN; OTOTOXICITY; PRIORITY JOURNAL; WEIGHT GAIN;

AMIKACIN; ANIMALS; ANTI-BACTERIAL AGENTS; AUDITORY PATHWAYS; AUDITORY THRESHOLD; DEAFNESS; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; MALE; NEUROPROTECTIVE AGENTS; REACTION TIME; SODIUM CHANNEL BLOCKERS; SODIUM CHANNELS; SURVIVAL RATE; VINCA ALKALOIDS; WEIGHT GAIN;

EID: 0034705771     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(00)02333-7     Document Type: Article

References (34)

1. M. Akiyoshi K. Sato H. Nakada T. Tajima K. Suzuki Evaluation of ototoxicity of amikacin (BB-K8) by animal test Jpn. J. Antibiot. 28 1975 288 304
2. T. Araki H. Kato K. Kogure Comparative protective effects of vinconate, baclofen, and pentobarbital against neuronal damage following repeated brief cerebral ischemia in the gerbil brain Res. Exp. Med. 191 1991 371 378
3. T. Araki K. Kogure K. Nishioka Comparative neuroprotective effects of pentobarbital, vinpocetine, flunarizine and ifenprodil on ischemic neuronal damage in the gerbil hippocampus Res. Exp. Med. 190 1990 19 23
4. J.-M. Aran C. Chappert D. Dulon J.-P. Erre C. Aurousseau Uptake of amikacin by hair cells of the guinea pig cochlea and vestibule and ototoxicity: comparison with gentamicin Hear. Res. 82 1995 179 183
5. A.S. Basile J.M. Huang C. Xie D. Webster C. Berlin P. Skolnick N -methyl- d -aspartate antagonists limit aminoglycoside antibiotic-induced hearing loss Nature Med. 2 1996 1338 1343
6. A.R. Beaubien Delay in hearing loss following drug administration Acta Otolaryngol. 109 1990 345 352
7. E.J. Begg M.L. Barclay Aminoglycosides – 50 years on J. Clin. Pharmacol. 39 1995 597 603
8. R.E. Brummett R.B. Morrison The incidence of aminoglycoside antibiotic-induced hearing loss Arch. Otolaryngol. Head Neck Surg. 116 1990 406 410
9. B.J. Conlon J.-M. Aran J.-P. Erre D.W. Smith Attenuation of aminoglycoside-induced cochlear damage with the metabolic antioxidant α-lipoic acid Hear. Res. 128 1999 40 44
10. K. Ehrenberger D. Felix Receptor pharmacological models for inner ear therapies with emphasis on glutamate receptors: a survey Acta Otolaryngol. 115 1995 236 240
11. + channels Eur. J. Pharmacol. 314 1996 69 73
12. M. Eybalin Neurotransmitters and neuromodulators of the mammalian cochlea Physiol. Rev. 73 1993 309 373
13. S.L. Garetz R.A. Altschuler J. Schacht Attenuation of gentamicin ototoxicity by glutathione in guinea pig in vivo Hear. Res. 77 1994 81 87
14. H. Hiel J.-P. Erre C. Aurousseau R. Bouali D. Dulon J.-M. Aran Gentamicin uptake by cochlear hair cells precedes hearing impairment during chronic treatment Audiology 32 1993 78 87
15. I. Hindmarch H.H. Fuchs H. Erzigkeit Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes Int. Clin. Psychopharmacol. 6 1991 31 43
16. M.A. Hotz F.P. Harris R. Probst Otoacoustic emissions: an approach for monitoring aminoglycoside-induced ototoxicity Laryngoscope 104 1994 1130 1134
17. G.A. King Protective effects of vinpocetine and structurally related drugs on the lethal consequences of hypoxia in mice Arch. Int. Pharmacodyn. Ther. 286 1987 299 307
18. M. Lenoir J.-L. Puel Dose-dependent changes in the rat cochlea following aminoglycoside intoxication. II. Histological study Hear. Res. 26 1987 199 209
19. 2+ of NMDA responses in spinal cord neurons Nature 309 1984 261 263
20. L. Nowak P. Bregestovski P. Ascher A. Herbert Z. Prochiantz Magnesium gates glutamate activated channels in mouse central neurons Nature 307 1984 462 465
21. O.P. Ottersen Y. Takumi A. Matsubara A.S. Landsend J.H. Laake S. Usami Molecular organization of a type of peripheral glutamate synapse: the afferent synapses of hair cells in the inner ear Prog. Neurobiol. 54 1998 127 148
22. J.-L. Puel S. Ladrech R. Chabert R. Pujol M. Eybalin Electrophysiological evidence for the presence of NMDA receptors in the guinea pig cochlea Hear. Res. 51 1991 255 264
23. J.-L. Puel M. Lenoir A. Uziel Dose-dependent changes in the rat cochlea following aminoglycoside intoxication. I. Physiological study Hear. Res. 26 1987 191 197
24. J.-L. Puel R. Pujol F. Tribillac S. Ladrech M. Eybalin Excitatory amino acid antagonists protect cochlear auditory neurons from excitotoxicity J. Comp. Neurol. 341 1994 241 256
25. D. Sauer R. Rischke T. Beck C. Rozberg H.D. Mennel G.W. Bielenberg J. Krieglstein Vinpocetine prevents ischemic cell damage in rat hippocampus Life Sci. 43 1988 1733 1739
26. J.A. Segal B.D. Harris Y. Kustova A. Basile P. Skolnick Aminoglycoside neurotoxicity involves NMDA receptor activation Brain Res. 815 1999 270 277
27. M. Sharifzadeh M. Abdollahi H. Behrooz B. Minaii A. Kebriaeezadeh M.R. Kashani A.R. Dehpour N. Aghaebrahimi Effects of chronic lithium on ototoxicity induced by gentamicin and amikacin in guinea pigs Pharmacol. Toxicol. 83 1998 220 224
28. M. Sitges V. Nekrassov Vinpocetine selectively inhibits neurotransmitter release triggered by sodium channel activation Neurochem. Res. 24 1999 1587 1593
29. B.-B. Song S.-H. Sha J. Schacht Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity Free Radic. Biol. Med. 25 1998 189 195
30. B. Song D.J. Anderson J. Schacht Protection from gentamicin ototoxicity by iron chelators in guinea pig in vivo J. Pharmacol. Exp. Ther. 282 1997 369 377
31. S.P. Stringer W.L. Meyerhoff C.G. Wright M.M. Paparella D.A. Shumrick J.L. Gluckman W.L. Meyerhoff Otolaryngology 1991 Saunders Philadelphia 1653 1669
32. C.P. Taylor L.S. Narasimhan Sodium channels and therapy of central nervous system diseases Adv. Pharmacol. 39 1999 47 98
33. + channels: a rational and effective strategy against ischemic brain damage Pharmacol. Rev. 48 1996 21 67
34. S. Usami A. Matsubara S. Fujita H. Shinkawa M. Hayashi NMDA (NMDAR1) and AMPA-type (GluR2/3) receptor subunits are expressed in the inner ear Neuroreport 6 1995 1161 1164